3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
3
Pain
2
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Vesico-Ureteral Reflux
1
Ureteral Neoplasms
1
Supratentorial Neoplasms
1
Pain, Intractable
1
Nephrolithiasis
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Leiomyoma
1
Kidney Neoplasms
1
Ileus
1
Chronic Pain
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Bone Marrow Failure Disorders
1
Anemia, Aplastic
1
Agnosia
1
Advanced Malignant Neoplasm
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Morphine
×
1 year
×
Clear all
No trials found.